K. Lindor

1.8k total citations
13 papers, 1.3k citations indexed

About

K. Lindor is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, K. Lindor has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Epidemiology and 3 papers in Rheumatology. Recurrent topics in K. Lindor's work include Liver Diseases and Immunity (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Systemic Lupus Erythematosus Research (3 papers). K. Lindor is often cited by papers focused on Liver Diseases and Immunity (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Systemic Lupus Erythematosus Research (3 papers). K. Lindor collaborates with scholars based in United States, Canada and United Kingdom. K. Lindor's co-authors include Karen Cauch‐Dudek, R Poupon, E. Jenny Heathcote, E. R. Dickson, R.E. Poupon, Jeffrey S. Crippin, Gregory J. Gores, J. Ludwig, Jorge Rakela and Andrea A. Gossard and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

K. Lindor

13 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Lindor United States 9 1.1k 933 441 253 214 13 1.3k
Imran Patanwala United Kingdom 9 729 0.7× 705 0.8× 378 0.9× 116 0.5× 137 0.6× 27 1.1k
Paolo De Paolis Italy 12 1.1k 1.0× 523 0.6× 455 1.0× 420 1.7× 225 1.1× 53 1.6k
Amitabh Suman United States 17 1.1k 1.0× 633 0.7× 508 1.2× 520 2.1× 212 1.0× 27 1.7k
Benedikt Simbrunner Austria 24 1.2k 1.1× 1.2k 1.2× 401 0.9× 115 0.5× 103 0.5× 104 1.6k
Emmanouil Sinakos Greece 18 739 0.7× 766 0.8× 544 1.2× 101 0.4× 147 0.7× 63 1.3k
Martine Walmsley United Kingdom 9 654 0.6× 564 0.6× 350 0.8× 115 0.5× 87 0.4× 25 1.0k
Edwyn M Harrison United States 13 1.2k 1.1× 1.1k 1.2× 1.0k 2.3× 353 1.4× 354 1.7× 16 2.1k
Tasuku Hara Japan 20 713 0.6× 419 0.4× 190 0.4× 322 1.3× 114 0.5× 51 1.0k
Iliana Doycheva United States 17 753 0.7× 386 0.4× 235 0.5× 311 1.2× 66 0.3× 22 1.0k
Rosa Lombardi Italy 24 1.1k 1.0× 546 0.6× 207 0.5× 419 1.7× 53 0.2× 73 1.5k

Countries citing papers authored by K. Lindor

Since Specialization
Citations

This map shows the geographic impact of K. Lindor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Lindor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Lindor more than expected).

Fields of papers citing papers by K. Lindor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Lindor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Lindor. The network helps show where K. Lindor may publish in the future.

Co-authorship network of co-authors of K. Lindor

This figure shows the co-authorship network connecting the top 25 collaborators of K. Lindor. A scholar is included among the top collaborators of K. Lindor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Lindor. K. Lindor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Harms, Maren H., Willem J. Lammers, Christophe Corpechot, et al.. (2018). Ursodeoxycholic acid treatment is associated with prolonged transplant-free survival in primary biliary cholangitis – even in patients without biochemical improvements. Journal of Hepatology. 68. S8–S8. 1 indexed citations
2.
Zhou, Yueren, Irina V. Haller, Robert J. Romanelli, et al.. (2017). Epidemiologic trends and treatment survival benefits in a US cohort of patients with primary biliary cholangitis (PBC).. 66. 1 indexed citations
3.
Hirschfield, Gideon M., M. Eric Gershwin, Richard E. Strauss, et al.. (2014). P367 PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WHO HAD AN INADEQUATE RESPONSE TO URSODEOXYCHOLIC ACID. Journal of Hepatology. 60(1). S189–S190. 13 indexed citations
4.
Imam, Mohamad, Jayant A. Talwalkar, & K. Lindor. (2013). An update on primary sclerosing cholangitis:from pathogenesis to treatment.. PubMed. 59(1). 49–58. 3 indexed citations
5.
Mason, Andrew L., Velimir A. Luketic, K. Lindor, et al.. (2010). 2 FARNESOID-X RECEPTOR AGONISTS: A NEW CLASS OF DRUGS FOR THE TREATMENT OF PBC? AN INTERNATIONAL STUDY EVALUATING THE ADDITION OF INT-747 TO URSODEOXYCHOLIC ACID. Journal of Hepatology. 52. S1–S2. 60 indexed citations
6.
Mason, Andrew L., K. Lindor, Bruce R. Bacon, et al.. (2008). Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. Alimentary Pharmacology & Therapeutics. 28(7). 886–894. 42 indexed citations
7.
Kaya, Mehmet Salih, Paul Angulo, & K. Lindor. (2000). Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring systemNote. Journal of Hepatology. 33(4). 537–542. 44 indexed citations
8.
Poupon, R.E., K. Lindor, Karen Cauch‐Dudek, et al.. (1997). Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 113(3). 884–890. 457 indexed citations
9.
Laurin, Jacqueline, K. Lindor, Jeffrey S. Crippin, et al.. (1996). Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study. Hepatology. 23(6). 1464–1467. 456 indexed citations
10.
Ludwig, J., et al.. (1995). Antimitochondrial antibody-negative primary biliary cirrhosis.. PubMed. 90(2). 247–9. 128 indexed citations
11.
Lindor, K., et al.. (1993). Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patients.. PubMed. 88(8). 1254–7. 24 indexed citations
12.
Crippin, Jeffrey S., K. Lindor, Roberta A. Jorgensen, et al.. (1992). Hypercholesterolemia and Atherosclerosis in Primary Biliary Cirrhosis: What Is the Risk?. Hepatology. 15(5). 858–862. 112 indexed citations
13.
Lindor, K., et al.. (1986). Effects of cyclosporine on lymphocyte blastogenesis: Analysis of dose-response relationships and interindividual variability in healthy adults. 18(4). 915–917. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imran Patanwala Breakdown of academic impact, for papers by Paolo De Paolis Breakdown of academic impact, for papers by Amitabh Suman Breakdown of academic impact, for papers by Benedikt Simbrunner Breakdown of academic impact, for papers by Emmanouil Sinakos Breakdown of academic impact, for papers by Martine Walmsley Breakdown of academic impact, for papers by Edwyn M Harrison Breakdown of academic impact, for papers by Tasuku Hara Breakdown of academic impact, for papers by Iliana Doycheva Breakdown of academic impact, for papers by Rosa Lombardi
Rankless by CCL
2026